|
May 26, 2020
|
BioCryst to Present New Berotralstat Data at European Academy of Allergy and Clinical Immunology Digital Congress
|
|
|
May 15, 2020
|
BioCryst Celebrates HAE Patients with HAE Global Walk
|
|
|
May 07, 2020
|
BioCryst to Present at Upcoming Investor Conferences
|
|
|
May 06, 2020
|
BioCryst Reports First Quarter 2020 Financial Results and Upcoming Key Milestones
|
|
|
May 05, 2020
|
New Composition of Matter Patent Allowance Extends Protection for Berotralstat in U.S. Market by Four Years to 2039
|
|
|
May 04, 2020
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
|
Apr 22, 2020
|
BioCryst to Report First Quarter 2020 Financial Results on May 6
|
|
|
Apr 09, 2020
|
BioCryst Begins Clinical Trial with Galidesivir for Treatment of Patients with COVID-19
|
|
|
Apr 08, 2020
|
BioCryst to Present at 19th Annual Needham Healthcare Conference
|
|
|
Apr 03, 2020
|
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
